Director, Global Market Access and Pricing Strategy - Cell Therapy

At Bristol Myers Squibb, our employees often ask, “Who are you working for?”—a question that fuels collaboration, accountability, and urgency in our work. Our purpose-driven culture inspires us to discover, develop, and deliver innovative medicines to prevail over serious diseases. We offer uniquely interesting and meaningful work, opportunities for growth, and a supportive environment that values inclusion, wellbeing, flexibility, and comprehensive benefits.

This is work that transforms the lives of patients, and the careers of those who do it.

Summary:

The Director, Global Market Access and Pricing Strategy, Cell Therapy will be responsible for defining and driving integrated global market access, pricing, reimbursement, and launch/market expansion strategies for one or more assets across the Cell Therapy portfolio. The role may support marketed products, launch assets, or earlier-stage programs depending on business priorities, portfolio needs, and the experience of the successful candidate.

The Director will ensure that payer, pricing, evidence, policy, and value considerations are fully integrated into asset-level and portfolio-level decision making across development, launch preparation, commercialization, and lifecycle management. This role will report to the Executive Director, Global Market Access, Cell Therapy.

The position is highly strategic and cross-functional, operating within a complex, matrixed global organization. The Director will work in close partnership with the core Global Market Access team, including HEOR and Pricing leads, and with a broad extended team spanning Commercial, Medical Affairs, Clinical Development, Regulatory, Policy, Advocacy, and Business Insights & Analytics. The role will also actively engage with regional and local market access stakeholders worldwide to ensure global strategies are robust, coherent, adaptable, and executable in a rapidly evolving access landscape.

Success in this role requires a motivated, inclusive, and decisive leader with strong global access expertise, a proven ability to navigate complexity, and the confidence to make and communicate difficult strategic trade-offs. The successful candidate will bring a strong track record of shaping access strategy for oncology, hematology, specialty biologics, or advanced therapies; influencing senior-level decision making; and clearly articulating strategic recommendations across functions and levels of the organization.

Responsibilities:

• Lead the development and execution of integrated worldwide pricing, access, reimbursement, and launch strategies for assigned Cell Therapy assets across development, launch, commercialization, and lifecycle management. Define global pricing strategy, price corridors, access archetypes, launch sequencing considerations, and pricing assumptions, while balancing speed to patient access, sustainability of value, pricing discipline, and long-term franchise objectives
• Serve as the Worldwide Market Access lead to relevant Global Product Teams and governance forums, ensuring payer and HTA perspectives are embedded early and consistently into development and commercial strategies. Shape clinical development plans, registrational trial designs, and evidence generation priorities to address evolving payer and HTA requirements across key markets
• Collaborate across the Global Market Access organization, including Pricing, HEOR, US Access Strategy, and regional and local access teams, to holistically assess opportunities and risks. Translate market, policy, reimbursement, and competitive dynamics into clear strategic recommendations and practical mitigation plans
• Lead the Global Market Access Core Team, Value Strategy Team, or other cross-functional access forums for assigned assets, ensuring alignment across functions and geographies and driving clear strategic direction, prioritization, launch readiness, and execution
• Partner with Commercial, Medical Affairs, Clinical Development, Regulatory, Policy, Advocacy, Business Insights & Analytics, and regional teams to monitor the external environment and continuously adapt market access strategy across the asset lifecycle
• Contribute to Cell Therapy portfolio strategy, long-range planning, portfolio prioritization, and business development evaluations by providing integrated access, pricing, reimbursement, evidence, and policy perspectives. Build strong, trust-based relationships across functions and geographies to enable aligned decision making,…